Mark Temper
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 7
- Oncology 5
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Surgical Treatments 1
- Co-authors
- Tamar Peretz (7 shared papers)Azzam Salah (3 shared papers)Ayala Hubert (6 shared papers)Beatrice Uziely (4 shared papers)Esther Tahover (3 shared papers)Ilya V. Tsimafeyeu (1 shared paper)Myriam Maoz (1 shared paper)Meir Liebergall (1 shared paper)
- Journals
- Targeted Oncology (2 papers)Nature Biotechnology (2 papers)Medical Oncology (1 paper)BioMed Research International (1 paper)JCI Insight (1 paper)
- Partner nations
- IsraelUnited StatesUnited Arab Emirates
In The Last Decade
Mark Temper
15 papers receiving 359 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 139
- Drug Discovery 1
- Oncology 50
- Molecular Biology 98
- Biophysics 9
Countries citing papers authored by Mark Temper
This map shows the geographic impact of Mark Temper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Temper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Temper more than expected).
Fields of papers citing papers by Mark Temper
This network shows the impact of papers produced by Mark Temper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Temper. The network helps show where Mark Temper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Temper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 123 | |
| 2 | 2022 | 71 | |
| 3 | 2012 | 38 | |
| 4 | 2022 | 38 | |
| 5 | 2007 | 25 | |
| 6 | 2014 | 18 | |
| 7 | 2018 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2008 | 10 | |
| 10 | 2015 | 9 | |
| 11 | 2020 | 6 | |
| 12 | 2017 | 3 | |
| 13 | 2015 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 0 |
About Mark Temper
Mark Temper is a scholar working on Cancer Research, Oncology, Surgery, Molecular Biology and Genetics, having authored 16 papers that have together received 366 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Epigenetics and DNA Methylation (1 paper), RNA Research and Splicing (1 paper), Genomics and Chromatin Dynamics (1 paper), Advanced biosensing and bioanalysis techniques (1 paper) and Colorectal Cancer Surgical Treatments (1 paper). The work is most often cited by research in Cancer Research (139 citations), Drug Discovery (1 citation), Oncology (50 citations), Molecular Biology (98 citations) and Biophysics (9 citations). Mark Temper has collaborated with scholars based in Israel, United States and United Arab Emirates. Frequent co-authors include Tamar Peretz, Azzam Salah, Ayala Hubert, Beatrice Uziely, Esther Tahover, Ilya V. Tsimafeyeu, Myriam Maoz, Meir Liebergall, Noa Furth and Ekaterina N. Andreishcheva. Their work appears in journals such as Targeted Oncology, Nature Biotechnology, Medical Oncology, BioMed Research International and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.